USAID's COVID-19 Response

Speeches Shim

Collage of COVID-19 videos

COVID-19 is one of the greatest health challenges our world has ever faced. To beat the virus in the United States, we must also fight it abroad. USAID’s work to end the pandemic is keeping Americans safe, saving lives around the world, and rebuilding the U.S. and global economies.

 

We need to attack this virus globally, not just at home, because it’s in America’s self-interest to do so. The virus knows no boundaries. —President Joe Biden

USAID’s Global Response

COVID-19 knows no borders and no one is safe until everyone is safe. USAID is working around the clock to help save lives and end the pandemic for all. Since the beginning of the pandemic, USAID has supported more than 120 countries to contain and combat the virus. To date, USAID has provided more than $9 billion to intensify the fight against COVID-19 around the world, pave the way to global recovery, and strengthen global health security.

Only through collaboration can we collectively overcome COVID-19. —Administrator Samantha Power

USAID’s Programs

USAID is building on decades of global health leadership combating infectious diseases such as Ebola, HIV/AIDS, tuberculosis, and malaria to now fight COVID-19. USAID programs are helping deliver vaccines and get shots in arms, expand access to COVID-19 testing and treatment, protect and train health workers, deliver life-saving health commodities and equipment, share reliable public health information, and safeguard global health security. Yet USAID is not just fighting the disease—USAID is fighting to secure decades of development progress that the pandemic is unwinding. USAID programs are keeping kids in school, providing emergency food and hygiene assistance, helping people find work, preventing democratic backsliding, addressing gender-based violence, and tackling other devastating impacts of the pandemic.

USAID is committed to building back a better world, one that is better prepared to prevent, detect, and respond to future biological threats, and where all people can live safe, prosperous, and healthy lives. — USAID COVID-19 Task Force Director Jeremy Konyndyk

Resources

The spread of COVID-19 has shown that an infectious disease threat anywhere can be a threat everywhere. USAID is dedicated to ending this pandemic for everyone, everywhere.


LATEST UPDATES

USAID Operating Status

USAID OPERATING STATUS UPDATE AS OF 5/20/2020

Applies to: May 20, 2020 - Until Further Notice

STATUS: OPEN -- USAID EMPLOYEES REMAIN ON MANDATORY TELEWORK AND ARE AVAILABLE VIRTUALLY. ACCESS TO USAID DOMESTIC FACILITIES IS RESTRICTED AND REQUIRES THE APPROVAL OF THE AGENCY’S ACTING ADMINISTRATOR OR BUREAU/INDEPENDENT OFFICE HEADS. 

Last updated: November 19, 2021

November 18, 2021

As it is around the world, the COVID-19 situation in Latin America and the Caribbean remains dangerous. However, thanks to the generosity of the American people and the support of Congress, USAID has been able to help the countries of the region make real progress despite the unprecedented health and economic impacts of the pandemic. Even as we maintain our vigilance and continue to respond to the virus, we remain committed to helping countries adapt to new realities presented by the pandemic and shore up hard-won development gains. Ultimately, we seek to help the people of the region live in peace and prosperity and realize a more healthy, hopeful future.

U.S. Government Exceeds Two Million COVID-19 Vaccine Doses Donations to Tajikistan
November 15, 2021

Today, the United States delivered 117,000 out of 198,900 doses of the Pfizer vaccine to Tajikistan for the continued fight against the COVID-19 pandemic through the United States Agency for International Development (USAID) and the COVAX facility. The remaining 81,900 doses will arrive this week. This latest donation adds to the 325,260 Pfizer doses delivered in September, and 1.5 million Moderna doses delivered in July 2021. In total, the U.S. government has donated more than two million doses of COVID-19 vaccines in Tajikistan.

November 4, 2021

Today, the United States, through the United States Agency for International Development, announced $4.55 million in urgent COVID-19 assistance for Yemen. This assistance will provide much needed, life-saving oxygen for 25 COVID-19 isolation units and strengthen the country’s COVID-19 response to minimize the risk of the virus. 

November 3, 2021

Today, at Commune Health Station of Ward 5 in District 6, U.S. Acting Consul General Robert Greenan observed the integration of tuberculosis (TB) screening with the national COVID-19 vaccination campaign. Integrated TB screening is endorsed by the National TB Program, and with USAID assistance, Vietnam first deployed this integrated approach at COVID-19 vaccination sites in Hanoi last month with plans to expand it to Tien Giang and Can Tho provinces as well. At today’s COVID-19 vaccination event, community members from District 6 received their COVID-19 vaccine and all of those who were 55 years or older were provided with a free chest X-ray taken on an ultra-portable, hand-held X-ray device that detects signs of TB. After laboratory analysis all patients will receive their test results over the next three days and be referred to appropriate treatment if needed. This service is supported by USAID’s Erase TB project, a $2 million, three-year initiative to increase TB detection and access to care in Ho Chi Minh City and Hanoi. The integrated screenings are in partnership with the Ho Chi Minh City Department of Health, Pham Ngoc Thach Hospital, the District 6 People’s Committee, and local health workers. 

October 27, 2021

Thanks to Congress’ support, USAID and interagency partners have made great strides in the fight against COVID-19. But so much more remains to be done to end the pandemic and build back better. We will not be able to do this alone. USAID, in coordination with our interagency partners, is working closely with other donor governments, multilateral institutions, as well as philanthropic and the private sectors as our collective efforts are the only way we will be able to secure a future free of COVID-19.

We are entering the most operationally intensive year of the global response. Vaccine producers will increasingly supply low-income countries and COVAX in the coming months. We still foresee significant gaps and supply risks - several flagship vaccines continue to face production challenges that have delayed scale-up, and India’s export restrictions have been only marginally relaxed. We nonetheless expect that the supply outlook for lower-income countries will start to improve somewhat as we enter 2022. But with only three percent of low-income and only 36 percent of middle-income countries’ populations having received at least one vaccine dose, next year will require unprecedented outreach to successfully get shots into arms.

Pages